Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.

Identifieur interne : 000531 ( Main/Exploration ); précédent : 000530; suivant : 000532

Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.

Auteurs : Zerrin Orbak [Turquie] ; Fuat Laloglu [Turquie] ; Hulya Akat [Turquie]

Source :

RBID : pubmed:33183365

Descripteurs français

English descriptors

Abstract

The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.

DOI: 10.1017/S1047951120004291
PubMed: 33183365
PubMed Central: PMC7737124


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.</title>
<author>
<name sortKey="Orbak, Zerrin" sort="Orbak, Zerrin" uniqKey="Orbak Z" first="Zerrin" last="Orbak">Zerrin Orbak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Ataturk University, Erzurum</wicri:regionArea>
<wicri:noRegion>Erzurum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Laloglu, Fuat" sort="Laloglu, Fuat" uniqKey="Laloglu F" first="Fuat" last="Laloglu">Fuat Laloglu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Ataturk University, Erzurum</wicri:regionArea>
<wicri:noRegion>Erzurum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Akat, Hulya" sort="Akat, Hulya" uniqKey="Akat H" first="Hulya" last="Akat">Hulya Akat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Ataturk University, Erzurum</wicri:regionArea>
<wicri:noRegion>Erzurum</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33183365</idno>
<idno type="pmid">33183365</idno>
<idno type="doi">10.1017/S1047951120004291</idno>
<idno type="pmc">PMC7737124</idno>
<idno type="wicri:Area/Main/Corpus">000845</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000845</idno>
<idno type="wicri:Area/Main/Curation">000845</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000845</idno>
<idno type="wicri:Area/Main/Exploration">000845</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.</title>
<author>
<name sortKey="Orbak, Zerrin" sort="Orbak, Zerrin" uniqKey="Orbak Z" first="Zerrin" last="Orbak">Zerrin Orbak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Ataturk University, Erzurum</wicri:regionArea>
<wicri:noRegion>Erzurum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Laloglu, Fuat" sort="Laloglu, Fuat" uniqKey="Laloglu F" first="Fuat" last="Laloglu">Fuat Laloglu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Ataturk University, Erzurum</wicri:regionArea>
<wicri:noRegion>Erzurum</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Akat, Hulya" sort="Akat, Hulya" uniqKey="Akat H" first="Hulya" last="Akat">Hulya Akat</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Pediatrics, Ataturk University, Erzurum</wicri:regionArea>
<wicri:noRegion>Erzurum</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cardiology in the young</title>
<idno type="eISSN">1467-1107</idno>
<imprint>
<date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Ampicillin (therapeutic use)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Anticoagulants (therapeutic use)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Azithromycin (therapeutic use)</term>
<term>COVID-19 (complications)</term>
<term>COVID-19 (diagnostic imaging)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (physiopathology)</term>
<term>COVID-19 Nucleic Acid Testing (MeSH)</term>
<term>COVID-19 Serological Testing (MeSH)</term>
<term>Child (MeSH)</term>
<term>Drug Combinations (MeSH)</term>
<term>Enoxaparin (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Hypoxia (etiology)</term>
<term>Hypoxia (physiopathology)</term>
<term>Hypoxia (therapy)</term>
<term>Immunoglobulins, Intravenous (therapeutic use)</term>
<term>Immunologic Factors (therapeutic use)</term>
<term>Lopinavir (therapeutic use)</term>
<term>Lung (diagnostic imaging)</term>
<term>Male (MeSH)</term>
<term>Mucocutaneous Lymph Node Syndrome (drug therapy)</term>
<term>Mucocutaneous Lymph Node Syndrome (etiology)</term>
<term>Mucocutaneous Lymph Node Syndrome (physiopathology)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Oxygen Inhalation Therapy (MeSH)</term>
<term>Ritonavir (therapeutic use)</term>
<term>Sulbactam (therapeutic use)</term>
<term>Tomography, X-Ray Computed (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Ampicilline (usage thérapeutique)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Anticoagulants (usage thérapeutique)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Association médicamenteuse (MeSH)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Enfant (MeSH)</term>
<term>Facteurs immunologiques (usage thérapeutique)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Hypoxie (physiopathologie)</term>
<term>Hypoxie (thérapie)</term>
<term>Hypoxie (étiologie)</term>
<term>Immunoglobulines par voie veineuse (usage thérapeutique)</term>
<term>Lopinavir (usage thérapeutique)</term>
<term>Maladie de Kawasaki (physiopathologie)</term>
<term>Maladie de Kawasaki (traitement médicamenteux)</term>
<term>Maladie de Kawasaki (étiologie)</term>
<term>Mâle (MeSH)</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Oxygénothérapie (MeSH)</term>
<term>Poumon (imagerie diagnostique)</term>
<term>Ritonavir (usage thérapeutique)</term>
<term>Sulbactam (usage thérapeutique)</term>
<term>Tomodensitométrie (MeSH)</term>
<term>Énoxaparine (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Ampicillin</term>
<term>Anti-Bacterial Agents</term>
<term>Anticoagulants</term>
<term>Antiviral Agents</term>
<term>Azithromycin</term>
<term>Enoxaparin</term>
<term>Hydroxychloroquine</term>
<term>Immunoglobulins, Intravenous</term>
<term>Immunologic Factors</term>
<term>Lopinavir</term>
<term>Oseltamivir</term>
<term>Ritonavir</term>
<term>Sulbactam</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en">
<term>COVID-19</term>
<term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>COVID-19</term>
<term>Mucocutaneous Lymph Node Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Hypoxia</term>
<term>Mucocutaneous Lymph Node Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr">
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Hypoxie</term>
<term>Maladie de Kawasaki</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>COVID-19</term>
<term>Hypoxia</term>
<term>Mucocutaneous Lymph Node Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Hypoxia</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Hypoxie</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Maladie de Kawasaki</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Ampicilline</term>
<term>Antibactériens</term>
<term>Anticoagulants</term>
<term>Antiviraux</term>
<term>Azithromycine</term>
<term>Facteurs immunologiques</term>
<term>Hydroxychloroquine</term>
<term>Immunoglobulines par voie veineuse</term>
<term>Lopinavir</term>
<term>Oséltamivir</term>
<term>Ritonavir</term>
<term>Sulbactam</term>
<term>Énoxaparine</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Hypoxie</term>
<term>Maladie de Kawasaki</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>COVID-19 Nucleic Acid Testing</term>
<term>COVID-19 Serological Testing</term>
<term>Child</term>
<term>Drug Combinations</term>
<term>Humans</term>
<term>Male</term>
<term>Oxygen Inhalation Therapy</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Association médicamenteuse</term>
<term>Enfant</term>
<term>Humains</term>
<term>Mâle</term>
<term>Oxygénothérapie</term>
<term>Tomodensitométrie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">33183365</PMID>
<DateCompleted>
<Year>2021</Year>
<Month>03</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>03</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1467-1107</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>31</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2021</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Cardiology in the young</Title>
<ISOAbbreviation>Cardiol Young</ISOAbbreviation>
</Journal>
<ArticleTitle>Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.</ArticleTitle>
<Pagination>
<MedlinePgn>507-510</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1017/S1047951120004291</ELocationID>
<Abstract>
<AbstractText>The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Orbak</LastName>
<ForeName>Zerrin</ForeName>
<Initials>Z</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0002-1847-9844</Identifier>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laloglu</LastName>
<ForeName>Fuat</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akat</LastName>
<ForeName>Hulya</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Ataturk University, Erzurum, Turkey.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>11</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Cardiol Young</MedlineTA>
<NlmUniqueID>9200019</NlmUniqueID>
<ISSNLinking>1047-9511</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>65DT0ML581</RegistryNumber>
<NameOfSubstance UI="C035444">sultamicillin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7C782967RD</RegistryNumber>
<NameOfSubstance UI="D000667">Ampicillin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>S4TF6I2330</RegistryNumber>
<NameOfSubstance UI="D013407">Sulbactam</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000667" MajorTopicYN="N">Ampicillin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000087123" MajorTopicYN="N">COVID-19 Nucleic Acid Testing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000087124" MajorTopicYN="N">COVID-19 Serological Testing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017984" MajorTopicYN="N">Enoxaparin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009080" MajorTopicYN="N">Mucocutaneous Lymph Node Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010102" MajorTopicYN="Y">Oxygen Inhalation Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013407" MajorTopicYN="N">Sulbactam</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Kawasaki disease</Keyword>
<Keyword MajorTopicYN="N">pneumonia</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>3</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>11</Month>
<Day>13</Day>
<Hour>5</Hour>
<Minute>33</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33183365</ArticleId>
<ArticleId IdType="pii">S1047951120004291</ArticleId>
<ArticleId IdType="doi">10.1017/S1047951120004291</ArticleId>
<ArticleId IdType="pmc">PMC7737124</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Turquie</li>
</country>
</list>
<tree>
<country name="Turquie">
<noRegion>
<name sortKey="Orbak, Zerrin" sort="Orbak, Zerrin" uniqKey="Orbak Z" first="Zerrin" last="Orbak">Zerrin Orbak</name>
</noRegion>
<name sortKey="Akat, Hulya" sort="Akat, Hulya" uniqKey="Akat H" first="Hulya" last="Akat">Hulya Akat</name>
<name sortKey="Laloglu, Fuat" sort="Laloglu, Fuat" uniqKey="Laloglu F" first="Fuat" last="Laloglu">Fuat Laloglu</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000531 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000531 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33183365
   |texte=   Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33183365" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021